All Stories

  1. Depressive symptoms as mediator between adverse childhood events and fecal incontinence and constipation in community-dwelling men and women
  2. Effectiveness of different de-implementation strategies in primary care: systematic review and meta-analysis
  3. Exploring patient involvement and influencing factors in digital interdisciplinary consultation
  4. General practitioners’ perspectives on diagnosis and treatment of uncomplicated urinary tract infections: A qualitative study in the Northern Dutch–German cross-border region
  5. Impact of an interdisciplinary digital consultation platform on general practitioner referrals for musculoskeletal symptoms: a stepped wedge cluster randomized trial
  6. Perceptions, facilitators and barriers of digital interdisciplinary consultation: a qualitative study
  7. Dutch Translation, Cultural Adaption, and Validation of the German Pelvic Floor Questionnaire for Pregnant and Postpartum Women
  8. The views of women and their physicians on decision-making for stress urinary incontinence
  9. Shared Decision-Making (SDM) for Female SUI: Current Practice in Three Western Countries
  10. Hasselt Corona Impact Study: Impact of COVID-19 on healthcare seeking in a small Dutch town
  11. Critical Appraisal of Guidelines for Daytime Urinary Incontinence in Children: Evaluation of Quality and Recommendations on Diagnostics
  12. Critical Appraisal of Guidelines for Daytime Urinary Incontinence in Children: Comparison of Recommendations on Treatment
  13. Patients’ Perceptions of Stress Urinary Incontinence Treatment: A Scoping Review of Qualitative Studies
  14. Protocol for a Series of Systematic Reviews and Network Meta-analyses of Randomized Controlled Trials of Medications for Patients with Overactive Bladder Symptoms
  15. Urinary incontinence among Jordanian women: Prevalence, types, and associated factors
  16. Which patients are at risk of developing symptom diagnoses that persist for more than a year in primary care? Development and external validation of a prediction model
  17. Mid- to long-term results of Polyacrylamide Hydrogel (Bulkamid®) as recourse for female stress urinary incontinence
  18. Trends in C reactive protein testing: a retrospective cohort study in paediatric ambulatory care settings
  19. The association of fecal incontinence, constipation, and pelvic pain with the course of lower urinary tract symptoms in community‐dwelling men and women
  20. Qualitative study on shared decision making in cystitis management in general practice
  21. Differences in help-seeking behaviour between males and females with multiple pelvic floor symptoms: A qualitative study
  22. Sex differences in the association between (sexual) abuse and lower urinary tract symptoms
  23. Gaat gebruik van een menstruatiecup samen met een spiraal?
  24. Data Resource Profile: Registry of electronic health records of general practices in the north of The Netherlands (AHON)
  25. Zoveel mogelijk niets doen
  26. Depressive feelings as mediator in the relation between adverse childhood events and lower urinary tract symptoms in males and females
  27. Recurrence of non-muscle invasive bladder carcinoma after transurethral resection with hexaminolevulinate photodynamic diagnosis or regular cystoscopy
  28. Study protocol for a nationwide implementation of internet-based vestibular rehabilitation for patients with chronic vestibular symptoms (I-RECOVER)
  29. Development and feasibility of a telemedicine tool for patients with recurrent urinary tract infection: myRUTIcoach
  30. Challenges In Performing An Individual Participant–level Data Meta-analysis
  31. Reporting of costs and economic impacts in randomized trials of de-implementation interventions for low-value care: a systematic scoping review
  32. Systematic Reviews and Meta-analyses of the Procedure-specific Risks of Thrombosis and Bleeding in General Abdominal, Colorectal, Upper Gastrointestinal, and Hepatopancreatobiliary Surgery
  33. Differences in help-seeking behaviour between men and women with multiple pelvic floor symptoms: a qualitative study
  34. Care provider views on app-based treatment for female urinary incontinence: A mixed-methods study
  35. Perspective of Dutch healthcare professionals on care for female urinary incontinence: A mixed-methods study
  36. Differences and similarities in teledermatological primary care case histories between people with different skin tones
  37. Seeking consultation for urinary incontinence: Behaviours and barriers among Jordanian women
  38. Managing children with daytime urinary incontinence: a survey of Dutch general practitioners
  39. Geen pillen, maar bewegen bij chronische duizeligheid
  40. Timing of symptomatic venous thromboembolism after surgery: meta-analysis
  41. The test−retest reproducibility of the multiple array probe Leiden in men with lower urinary tract symptoms
  42. Comparing male and female pelvic floor muscle function by the number and type of pelvic floor symptoms
  43. Comparing Single-Incision Midurethral Sling with Bulking Agents for Female Stress Urinary Incontinence: Rationale for a Non-Randomized Controlled Trial
  44. Impact of digital interdisciplinary consultation on secondary care referrals by general practitioners: a protocol for a stepped-wedge cluster randomised controlled trial
  45. Het beleid bij urine-incontinentie bij vrouwen
  46. Randomized controlled trials in de-implementation research: a systematic scoping review
  47. Magnetic Resonance Imaging–targeted Prostate Biopsy Compared with Systematic Prostate Biopsy in Biopsy-naïve Patients with Suspected Prostate Cancer
  48. Effectiveness and costs of a new framework for selecting absorbent urinary incontinence products compared with current practice: a cohort study
  49. Exploring concomitant pelvic floor symptoms in community‐dwelling females and males
  50. Association of Supply Source with Continence Product and Care Satisfaction in Patients with Urinary Incontinence
  51. Exploring pelvic floor muscle function in men with and without pelvic floor symptoms: A population‐based study
  52. Prediction model study focusing on eHealth in the management of urinary incontinence: the Personalised Advantage Index as a decision-making aid
  53. Prevalence of co-existing pelvic floor disorders: A scoping review in males and females
  54. Cost‐effectiveness of an app‐based treatment for urinary incontinence in comparison with care‐as‐usual in Dutch general practice: a pragmatic randomised controlled trial over 12 months
  55. One year effectiveness of an app‐based treatment for urinary incontinence in comparison to care as usual in Dutch general practice: A pragmatic randomised controlled trial over 12 months
  56. Intercollegiale digitale psychiatrische consultaties
  57. Evaluation of the First Year(s) of Physicians Collaboration on an Interdisciplinary Electronic Consultation Platform in the Netherlands: Mixed Methods Observational Study
  58. Quality appraisal of clinical guidelines for recurrent urinary tract infections using AGREE II: a systematic review
  59. Primary care diagnostic and treatment pathways in Dutch women with urinary incontinence
  60. Online Consultations Between General Practitioners and Psychiatrists in the Netherlands: A Qualitative Study
  61. Evidence-based Urology: Understanding Heterogeneity in Systematic Reviews
  62. Identifying women’s preferences for treatment of urinary tract infection: a discrete choice experiment
  63. The patient pathway for overactive bladder management: A quantitative analysis
  64. Systematic reviews of observational studies of Risk of Thrombosis and Bleeding in General and Gynecologic Surgery (ROTBIGGS): introduction and methodology
  65. Evaluation of the First Year(s) of Physicians Collaboration on an Interdisciplinary Electronic Consultation Platform in the Netherlands: Mixed Methods Observational Study (Preprint)
  66. Barriers and Facilitators Associated With App-Based Treatment for Female Urinary Incontinence: Mixed Methods Evaluation
  67. Parents' expectations of the outpatient care for daytime urinary incontinence in children: A qualitative study
  68. Comparison of the diagnostic yield of routine versus indicated flowmetry, ultrasound and cystoscopy in women with recurrent urinary tract infections
  69. App voor zelfmanagement van urine-incontinentie bij vrouwen
  70. App-Based Treatment in Primary Care for Urinary Incontinence: A Pragmatic, Randomized Controlled Trial
  71. Wanneer is onderzoek nodig bij prostaatkanker in de familie?
  72. Expectations and Perceptions of Dutch Pharmacy Staff Regarding a New Framework for Continence Care: A Focus Group Study
  73. General practitioners’ approaches to prostate-specific antigen testing in the north-east of the Netherlands
  74. Assessment and treatment of recurrent urinary tract infections in women: development of a questionnaire based on a qualitative study of patient expectations in secondary care
  75. Barriers and Facilitators Associated With App-Based Treatment for Female Urinary Incontinence: Mixed Methods Evaluation (Preprint)
  76. Telemonitoring for Patients With COVID-19: Recommendations for Design and Implementation
  77. Intrinsic motivation of GPs was not related to recruitment success, whereas interest in the study topic was
  78. <p>What Do Men with Lower Urinary Tract Symptoms Expect from a Urologist in Secondary Care?</p>
  79. Factors affecting patient recruitment to trials: qualitative research in general practice
  80. Standardising definitions for the pre-eclampsia core outcome set: A consensus development study
  81. User Experiences and Preferences Regarding an App for the Treatment of Urinary Incontinence in Adult Women: Qualitative Study
  82. Telemonitoring for Patients With COVID-19: Recommendations for Design and Implementation (Preprint)
  83. A core outcome set for pre‐eclampsia research: An international consensus development study
  84. Recruitment through media and general practitioners resulted in comparable samples in an RCT on incontinence
  85. Wat als prostaatkanker in de familie voorkomt?
  86. Exploring pelvic floor muscle activity in men with lower urinary tract symptoms
  87. Determining the minimal important differences in the International Prostate Symptom Score and Overactive Bladder Questionnaire: results from an observational cohort study in Dutch primary care
  88. User Experiences and Preferences Regarding an App for the Treatment of Urinary Incontinence in Adult Women: Qualitative Study (Preprint)
  89. Discontinuation of alpha-blocker therapy in men with lower urinary tract symptoms: a systematic review and meta-analysis
  90. Patients’ Attitudes Towards Deprescribing Alpha-Blockers and Their Willingness to Participate in a Discontinuation Trial
  91. Effectiveness of a newly developed online self‐management program for male patients with uncomplicated lower urinary tract symptoms
  92. Symptom improvement and predictors associated with improvement after 6 weeks of alpha-blocker therapy: An exploratory, single-arm, open-label cohort study
  93. Scientific evidence for pelvic floor devices presented at conferences: An overview
  94. Development of an online personalized self‐management intervention for men with uncomplicated LUTS
  95. The effectiveness and cost-effectiveness of e-health interventions for depression and anxiety in primary care: A systematic review and meta-analysis
  96. International Continence Society (ICS) report on the terminology for nocturia and nocturnal lower urinary tract function
  97. Continuation rates of alpha-blockers mono-therapy in adult men, prescribed by urologists or general practitioners: a pharmacy-based study
  98. Prostate cancer screening with prostate-specific antigen (PSA) test: a clinical practice guideline
  99. Desmopressine helpt niet bij nycturie
  100. Gender differences in the evaluation of care for patients with type 2 diabetes: a cross-sectional study (ZODIAC-52)
  101. The impact of a mobile application-based treatment for urinary incontinence in adult women: Design of a mixed-methods randomized controlled trial in a primary care setting
  102. Blended care vs. usual care in the treatment of depressive symptoms and disorders in general practice [BLENDING]: study protocol of a non-inferiority randomized trial
  103. A systematic review of the psychological impact of false-positive colorectal cancer screening: What is the role of the general practitioner?
  104. Pelvic floor muscle therapy or alpha‐blocking agents for treatment of men with lower urinary tract symptoms: An exploratory randomized controlled trial
  105. Misoprostol voorafgaand aan IUD-plaatsing
  106. Dientamoeba fragiliscolonization is not associated with gastrointestinal symptoms in children at primary care level
  107. Abstracts
  108. Ultrasound for Distal Forearm Fracture: A Systematic Review and Diagnostic Meta-Analysis
  109. Moderate agreement between bladder capacity assessed by frequency volume charts and uroflowmetry, in adolescent and adult enuresis patients
  110. No evidence (yet) to support the statement ‘lower urinary tract symptoms (LUTS) - an independent risk factor for cardiovascular disease (CVD)’
  111. Reference values for frequency volume chart and uroflowmetry parameters in adolescent and adult enuresis patients
  112. Mictieklachten bij mannen – meer dan een vergrote prostaat
  113. De bekkenbodem belicht
  114. Predictors for a positive outcome of adapted clinical dry bed training in adolescents and adults with enuresis
  115. Lokale nitraten bij het fenomeen van Raynaud
  116. Abstracts
  117. Re: Farhad Islami, Daniel M. Moreira, Paolo Boffetta, Stephen J. Freedland. A Systematic Review and Meta-analysis of Tobacco Use and Prostate Cancer Mortality and Incidence in Prospective Cohort Studies. Eur Urol 2014;66:1054–64
  118. Important Differences Between Nocturnal Urine Production and Nocturnal Voiding Frequency
  119. Nocturia: Current Levels of Evidence and Recommendations From the International Consultation on Male Lower Urinary Tract Symptoms
  120. Validation of the howRu and howRwe questionnaires at the individual patient level
  121. Do lower urinary tract symptoms predict cardiovascular diseases in older men? A systematic review and meta-analysis
  122. RE: Cost-effectiveness of Prostate Cancer Screening: A Simulation Study Based on ERSPC Data
  123. 608 High short-term effectiveness of modulated dry bed training in adolescents and young adults with treatment-resistant enuresis
  124. Impact of the International Continence Society (ICS) report on the standardisation of terminology in nocturia on the quality of reports on nocturia and nocturnal polyuria: a systematic review
  125. Re: Long-Term Followup of Children with Nocturnal Enuresis: Increased Frequency of Nocturia in Adulthood
  126. A Systematic Review and Meta-analysis of Tobacco Use and Prostate Cancer Mortality and Incidence in Prospective Cohort Studies
  127. Measuring symptomatic relief in men with lower urinary tract symptoms
  128. Determinants of nocturia severity in men, derived from frequency–volume charts
  129. Are lower urinary tract symptoms associated with cardiovascular disease in the Dutch general population? Results from the Krimpen study
  130. Preventieconsult: geen bewijs van effectiviteit
  131. Determinants of Nocturia: the Krimpen Study
  132. The Association between Nocturia and Nocturnal Polyuria in Clinical and Epidemiological Studies: A Systematic Review and Meta-Analyses
  133. Outcomes of Pregnancy in Women With Hereditary Hemorrhagic Telangiectasia
  134. PSA-screening geen effect op sterfte
  135. Desmopressine bij nycturie
  136. 41 Kennis en attitude van huisartsen en niet-urologische specialisten over prostaatkankerscreening
  137. Impact of the European Randomized Study of Screening for Prostate Cancer (ERSPC) on prostate-specific antigen (PSA) testing by Dutch general practitioners
  138. Medicamenteus beleid bij mannen met mictieklachten
  139. Prevalence, Incidence, and Resolution of Nocturnal Polyuria in a Longitudinal Community-based Study in Older Men: The Krimpen Study
  140. The New England Research Institutes, Inc. (NERI) Nocturia Advisory Conference 2012: focus on outcomes of therapy
  141. Prostate specific antigen testing policy worldwide varies greatly and seems not to be in accordance with guidelines: a systematic review
  142. Orthostatic hypotension, diabetes, and falling in older patients: a cross-sectional study
  143. Editorial Comment
  144. Pressure during decision making of continuous sedation in end-of-life situations in Dutch general practice
  145. A new approach to patients with lower urinary tract symptoms
  146. Re: Kojima Y, et al. Tamsulosin reduces nighttime urine production in benign prostatic hyperplasia patients with nocturnal polyuria: A prospective open-label long-term study using frequency-volume chart. Neurourol Urodyn 2012;31:80-85.
  147. Mortality in Older Men With Nocturia. A 15-Year Followup of the Krimpen Study
  148. 1743 WHAT PREDICTS INCIDENT NOCTURIA? A POPULATION-BASED STUDY IN OLDER MEN: THE KRIMPEN STUDY
  149. Once Nocturia, Always Nocturia? Natural History of Nocturia in Older Men Based on Frequency-Volume Charts: The Krimpen Study
  150. The Natural History and Predictive Factors of Voided Volume in Older Men: The Krimpen Study
  151. Physicians' and Nurses' Experiences With Continuous Palliative Sedation in the Netherlands
  152. Editorial Comment
  153. Re: Erectile Dysfunction—An Observable Marker of Diabetes Mellitus? A Large National Epidemiological Study
  154. Terminale sedatie met midazolam bij patiënten in de huisartsenpraktijk
  155. CHANGES IN DISEASE SPECIFIC AND GENERIC QUALITY OF LIFE RELATED TO CHANGES IN LOWER URINARY TRACT SYMPTOMS: THE KRIMPEN STUDY
  156. Loss to Follow-Up in a Longitudinal Study on Urogenital Tract Symptoms in Dutch Older Men
  157. Incidence rates of erectile dysfunction in the Dutch general population. Effects of definition, clinical relevance and duration of follow-up in the Krimpen Study
  158. Prostate Cancer Detection in Older Men with and without Lower Urinary Tract Symptoms: A Population-Based Study
  159. Reason to screen for prostate cancer based on selective referencing
  160. Validity of Questionnaires
  161. Prostatectomy or Watchful Waiting in Prostate Cancer
  162. Nocturia in relation to sleep, somatic diseases and medical treatment in the elderly
  163. Prevalence of erectile dysfunction: a systematic review of population-based studies
  164. Normal Values and Determinants of Circadian Urine Production in Older Men: A Population Based Study
  165. Lipid-lowering drugs and erectile dysfunction
  166. Relation between nocturnal voiding frequency and nocturnal urine production in older men:a population-based study
  167. Normal Values and Determinants of Circadian Urine Production in Older Men: A Population Based Study
  168. Health Status and its Correlates among Dutch Community-Dwelling Older Men with and without Lower Urogenital Tract Dysfunction
  169. Strong effects of definition and nonresponse bias on prevalence rates of clinical benign prostatic hyperplasia: the Krimpen study of male urogenital tract problems and general health status
  170. Voided volumes: normal values and relation to lower urinary tract symptoms in elderly men, a community-based study
  171. Correlates for Erectile and Ejaculatory Dysfunction in Older Dutch Men: A Community‐Based Study
  172. Erectile and ejaculatory dysfunction in a community-based sample of men 50 to 78 years old: prevalence, concern, and relation to sexual activity
  173. NORMAL VOIDING PATTERNS AND DETERMINANTS OF INCREASED DIURNAL AND NOCTURNAL VOIDING FREQUENCY IN ELDERLY MEN
  174. NORMAL VOIDING PATTERNS AND DETERMINANTS OF INCREASED DIURNAL AND NOCTURNAL VOIDING FREQUENCY IN ELDERLY MEN